MULTIDRUG-RESISTANCE IS MORE THAN MDR1 ACTIVITY

被引：16

作者：

PREISLER, HD

机构：

来源：

关键词：

D O I：

10.1016/0145-2126(95)00003-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：429 / 431

页数：3

共 39 条

[1] UNKNOTTING THE COMPLEXITIES OF MULTIDRUG RESISTANCE - THE INVOLVEMENT OF DNA TOPOISOMERASES IN DRUG-ACTION AND RESISTANCE
BECK, WT
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (22): : 1683 - 1685
[2] BEGG AC, 1992, SEMIN RADIAT ONCOL, V2, P22
[3] CLINICAL-EVIDENCE FOR TUMOR CLONOGEN REGENERATION - INTERPRETATIONS OF THE DATA
BENTZEN, SM
THAMES, HD
[J]. RADIOTHERAPY AND ONCOLOGY, 1991, 22 (03) : 161 - 166
[4] BIEDLER JL, 1970, CANCER RES, V30, P1174
[5] P53 MUTATIONS, ANOTHER BREAST-CANCER PROGNOSTIC FACTOR
CALLAHAN, R
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (11) : 826 - 827
[6] CAMPOS L, 1993, BLOOD, V81, P3091
[7] CHRISTENSSON B, 1986, CANCER, V58, P1295, DOI 10.1002/1097-0142(19860915)58:6<1295::AID-CNCR2820580620>3.0.CO
[8] 2-H
[9] PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY
CLARK, GM
DRESSLER, LG
OWENS, MA
POUNDS, G
OLDAKER, T
MCGUIRE, WL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) : 627 - 633
[10] THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS
CLARKE, AR
PURDIE, CA
HARRISON, DJ
MORRIS, RG
BIRD, CC
HOOPER, ML
WYLLIE, AH
[J]. NATURE, 1993, 362 (6423) : 849 - 852